Global Macro Service > Research Briefings > Global
Suspension of AstraZeneca vaccinations in a number of European economies, news of more vaccine supply problems, and rising Covid case numbers globally are all indications that the transition to normality will be uneven. But we don’t see these bumps as sufficient grounds to cut our economic forecasts.
To read the full briefing please
If you are not a subscriber, request a free trial of our Global Macro Service by filling out the form below